Yan Mo
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Protein Degradation and Inhibitors 1
- Oncology 5
- Cancer Cells and Metastasis 2
- Chemokine receptors and signaling 2
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Kun‐Liang Guan (4 shared papers)Yue Xiong (4 shared papers)Qun‐Ying Lei (2 shared papers)Di Zhao (2 shared papers)Ying Liu (1 shared paper)Bo Dong (1 shared paper)Xin Zhou (1 shared paper)Ping Wang (1 shared paper)
- Journals
- Journal of Clinical Investigation (2 papers)Cancer Cell (1 paper)Cell Death and Disease (1 paper)Cancer Letters (1 paper)FEBS Journal (1 paper)
- Partner nations
- ChinaUnited StatesSri Lanka
In The Last Decade
Yan Mo
12 papers receiving 573 citations
Peers
Comparison fields: 5 of 74
- Geriatrics and Gerontology 112
- Cancer Research 197
- Physiology 38
- Oncology 168
- Molecular Biology 341
Countries citing papers authored by Yan Mo
This map shows the geographic impact of Yan Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Mo more than expected).
Fields of papers citing papers by Yan Mo
This network shows the impact of papers produced by Yan Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Mo. The network helps show where Yan Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 275 | |
| 2 | 2014 | 133 | |
| 3 | 2017 | 59 | |
| 4 | 2019 | 32 | |
| 5 | 2022 | 31 | |
| 6 | 2022 | 16 | |
| 7 | 2017 | 16 | |
| 8 | 2022 | 12 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 1 |
About Yan Mo
Yan Mo is a scholar working on Molecular Biology, Oncology, Immunology, Geriatrics and Gerontology and Cancer Research, having authored 12 papers that have together received 583 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cancer Cells and Metastasis (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Chemokine receptors and signaling (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Geriatrics and Gerontology (112 citations), Cancer Research (197 citations), Physiology (38 citations), Oncology (168 citations) and Molecular Biology (341 citations). Yan Mo has collaborated with scholars based in China, United States and Sri Lanka. Frequent co-authors include Kun‐Liang Guan, Yue Xiong, Qun‐Ying Lei, Di Zhao, Ying Liu, Bo Dong, Xin Zhou, Ping Wang, Ran Lin and Xianlu Zeng. Their work appears in journals such as Journal of Clinical Investigation, Cancer Cell, Cell Death and Disease, Cancer Letters and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.